Future Science GroupBrowse
Supplemental table 1.docx (19.43 kB)
Download file

Supplementary Material: Treatment and Overall Survival Among Anti-PD-1 Exposed Advanced Melanoma Patients with Evidence of Disease Progression

Download (19.43 kB)
dataset
posted on 2021-12-06, 16:19 authored by Cathy Anne Pinto, Xinyue Liu, Xiaoyun Li, Emilie Scherrer, Mizuho Kalabis
Table S1 Patient characteristics by type of index therapy

Funding

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.

History

Usage metrics

Read the peer-reviewed publication

Treatment and Overall Survival Among Anti-PD-1 Exposed Advanced Melanoma Patients with Evidence of Disease Progression
ImmunotherapyImmunotherapy

Categories

Keywords

Cohort studyadvanced melanomaresistance to immunotherapytreatmentoverall survivalCancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0

Exports